AbbVie Puts Up $650M to Join Emerging But Crowded Area of Cancer Drug R&D
AbbVie is diversifying its oncology pipeline, paying $650 million for a clinical-stage drug that goes after two targets to fight ...
Tag: AbbVie
AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma
Antibodies that bind to two targets are an established way of treating the blood cancer multiple myeloma. Aiming to top ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!